Market Overview

Life Technologies Signs Licensing Agreement with iPS Academia Japan


Life Technologies Corporation (NASDAQ: LIFE) today announced that it has deepened its commitment to stem cell research and its customers by signing a non-exclusive agreement with iPS Academia Japan for its induced pluripotent stem (iPS) cell patent portfolio. The worldwide license will enable Life Technologies, a leading provider of innovative life science solutions, to expand its range of products and services for the iPS cell research community.

Posted-In: News Contracts


Related Articles (LIFE)

Get Benzinga's Newsletters